Global Spectral Computed Tomography Market

Spectral Computed Tomography Market Size, Share, Growth Analysis, By Product(Spiral CT, Electron Beam Tomography, Multi-slice Computed Tomography, Positron Emission Tomography (Pet) and Single-photon Emission Computed Tomography), By Application(Oncology, Neurology, Cardiology, Vascular and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2794 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 65 | Figures: 77

Spectral Computed Tomography Market Insights

Global Spectral Computed Tomography Market size was valued at USD 7.03 billion in 2022 and is poised to grow from USD 7.49 billion in 2023 to USD 12.39 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

Dual-energy computed tomography (DECT), sometimes called spectral CT, is an advance in the area of medical imaging that has been awaited for many years.

The technology is highly developed, and x-ray scanning has become a good source of information on anatomy. Moreover, among medical imaging equipment, presence in space humanizes the sentence. X-ray images produced by this spectrometer can be used to make very precise judgements regarding tissue composition and structure better than even computer axial tomography (CT) scanners at present.

Spectral computed tomography is used to combine two different bands of energy, and thus forms the basis for converting physical reality into concrete pictures based on material density.

One of the greatest advantages to this dual-energy method is that one can use high tech computer programs and get results far superior to those obtained from conventional single energy scanners, which rely on film. In fact, the biggest benefit of dual-energy CT is that it enables a more precise assessment of tissue characteristics than traditional CT scan while also yielding better imaging.

This technology employs two energy spectrums to better increase teeth of various tissues and thus facilitate more accurate diagnosis. This capability of seeing how materials react to different X-ray energies has led them into this higher level of precision.

In addition, the computer algorithms employed in dual-energy CT are key factors that significantly affect imaging quality and analysis. While single-energy CT scans are useful, they will not produce such precise results.

However, dual-energy CT algorithms can pick up extremely small differences in the composition of tissues and allow doctors to make appropriate images for use in planning treatment procedures and assisting with diagnosis. Spectral CT is a key development in medical imaging technology, and represents another powerful weapon for health practitioners.

This dual energy approach, combined with data extraction by powerful algorithms, does not just show high image quality X-rays but can even improve the accuracy and specificity of diagnostic information to help guide medical choices and achieve better patient outcomes.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Spectral Computed Tomography Market size was valued at USD 7.03 billion in 2022 and is poised to grow from USD 7.49 billion in 2023 to USD 12.39 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The market demonstrates a moderate level of consolidation, where a few major players hold a substantial portion of the revenue share. These key industry participants are strategically focused on introducing innovative products to solidify their positions in the market. 'Siemens Healthineers', 'GE Healthcare', 'Philips Healthcare', 'Toshiba Medical Systems Corporation', 'Hitachi Medical Corporation', 'Shimadzu Corporation', 'Carestream Health', 'Samsung Medison', 'Hologic, Inc.', 'Fujifilm Medical Systems', 'Esaote SpA', 'Agfa-Gevaert Group', 'Mindray Medical International Limited', 'Planmed', 'CurveBeam LLC', 'Medtronic plc', 'Konica Minolta, Inc.', 'Varian Medical Systems', 'Analogic Corporation', 'NeuroLogica Corporation', 'Xoran Technologies, LLC', 'Cubresa Inc.'

The Spectral Computed Tomography (CT) market is witnessing significant growth, driven by the promise of enhanced diagnostic accuracy. Spectral CT technology goes beyond conventional CT scanning by capturing data at different energy levels, allowing for a more detailed analysis of tissue composition and material characterization. This advancement enables healthcare professionals to obtain comprehensive insights into the underlying properties of tissues, leading to improved detection and characterization of various medical conditions. The ability to differentiate between different materials based on their spectral signatures enhances diagnostic precision, particularly in complex cases where traditional CT imaging may fall short. By providing a more nuanced understanding of tissue composition, Spectral CT contributes to early and accurate diagnoses, ultimately improving patient outcomes and paving the way for more personalized and effective medical interventions.

The Spectral CT market has seen unexpected advancements, predominantly in reducing radiation doses. This progress aligns with the increasing importance of patient safety and minimizing radiation exposure in medical imaging procedures. Spectral CT technology introduces novelties like dual-energy imaging, which enables better tissue characterization and visualization while substantially lowering the radiation dose required for scans. By utilizing different energy spectra, spectral CT optimizes imaging protocols to fold more information with summary radiation exposure, making it an invaluable advancement in diagnostic imaging, particularly for susceptible populations or individuals demanding recurrent scans.

In 2021 North America held a commanding position, accounting for 30.4 % of the market and with no one able to challenge over the forecast period. This was due to several factors, such as the concentration of market competitors in a relatively small area and an increase in cancer rates. According to the National Cancer Institute, 1,806,590 cancer sufferers were diagnosed in the U.S. alone during that same year (2020). Furthermore, the arrival of cutting-edge technology which incorporates elements from artificial intelligence as well as frequent launches for low radiation CT scans promise to spur even greater market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Spectral Computed Tomography Market

Report ID: SQMIG35A2794

$5,300
BUY NOW GET FREE SAMPLE